|
Printable version |
From: | "greg" <gregoire@paradise.net.nz> |
Date: | Wed, 18 Jul 2001 22:10:30 +1200 |
Yes, Graeme is correct.
Grant Samuel wrote an Independent Expert's Report
for FFS shareholders in January 2001.
In it he includes the $511m 'Shareholder Loan'
in working out the NTA.
He quotes an NTA of $1.69 at 30th June 2000
and converts this 'pro forma' to $0.58.
Pro forma is adjustment for rights issue, placement
of shares to RBC, sale of Biotech assets to RBC and separation
costs.
Also FFS has written its equity in the CNIFP down
to $0. So any bids for the assets over and above what the banks and FFS
are owed (and the receivers fees) will, as Graeme says get split between CITIC
and FFS.
|
|